glp 1 cardiac benefit Frontiers Reducing Risk of Major Adverse

This suggests that the medication treats the patient holistically rather than isolating a single symptom

Mitochondria-targeted therapeutics, MitoQ and BGP-15, reverse aging-associated meiotic spindle defects in mouse and human oocytes

Carnitine and its derivatives in cardiovascular disease 31

A focus on necroptosis and ferroptosis

Noom claims its microdose approach allows users to lose up to 11 pounds (around 5kg) in one month and up to 17 pounds in two months, with 70% of them reporting no side effects

The Western lifestyle with its ultra-processed foods, reliance on medications, and high exposure to chemicals or environmental pollutants seems to lay the foundation for the proliferation of free radicals